256 related articles for article (PubMed ID: 28577245)
1. From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis.
Bielefeldt K
Dig Dis Sci; 2017 Nov; 62(11):2999-3013. PubMed ID: 28577245
[TBL] [Abstract][Full Text] [Related]
2. Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited.
Al-Saffar A; Lennernäs H; Hellström PM
Neurogastroenterol Motil; 2019 Nov; 31(11):e13617. PubMed ID: 31050085
[TBL] [Abstract][Full Text] [Related]
3. The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits.
Ehrenpreis ED; Deepak P; Sifuentes H; Devi R; Du H; Leikin JB
Am J Gastroenterol; 2013 Jun; 108(6):866-72. PubMed ID: 23735907
[TBL] [Abstract][Full Text] [Related]
4. Metoclopramide for the treatment of diabetic gastroparesis.
Shakhatreh M; Jehangir A; Malik Z; Parkman HP
Expert Rev Gastroenterol Hepatol; 2019 Aug; 13(8):711-721. PubMed ID: 31314613
[No Abstract] [Full Text] [Related]
5. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
Svendsen K; Wood M; Olsson E; Nordeng H
Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
[TBL] [Abstract][Full Text] [Related]
6. Controversies in Gastroparesis: Discussing the Sticky Points.
Lacy BE; Cangemi DJ
Am J Gastroenterol; 2021 Aug; 116(8):1572-1576. PubMed ID: 33767098
[No Abstract] [Full Text] [Related]
7. Chronic metoclopramide therapy for diabetic gastroparesis.
Lata PF; Pigarelli DL
Ann Pharmacother; 2003 Jan; 37(1):122-6. PubMed ID: 12503946
[TBL] [Abstract][Full Text] [Related]
8. Domperidone is Commonly Prescribed With QT-Interacting Drugs: Review of a Community-based Practice and a Postmarketing Adverse Drug Event Reporting Database.
Ehrenpreis ED; Roginsky G; Alexoff A; Smith DG
J Clin Gastroenterol; 2017 Jan; 51(1):56-62. PubMed ID: 27182647
[TBL] [Abstract][Full Text] [Related]
9. Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide.
Pasricha PJ; Pehlivanov N; Sugumar A; Jankovic J
Nat Clin Pract Gastroenterol Hepatol; 2006 Mar; 3(3):138-48. PubMed ID: 16511548
[TBL] [Abstract][Full Text] [Related]
10. Current Status of Parkinsonism-Related Adverse Events and Associated Drugs in Korea.
Kim S; Suh HS
J Patient Saf; 2019 Dec; 15(4):e56-e59. PubMed ID: 28368965
[TBL] [Abstract][Full Text] [Related]
11. Gastroduodenal motility disorders.
Tack J; Van den Houte K; Carbone F
Curr Opin Gastroenterol; 2018 Nov; 34(6):428-435. PubMed ID: 30199408
[TBL] [Abstract][Full Text] [Related]
12. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
Patterson D; Abell T; Rothstein R; Koch K; Barnett J
Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
[TBL] [Abstract][Full Text] [Related]
13. [Metoclopramide-induced respiratory dyskinesia].
Vorre MM; Lange P
Ugeskr Laeger; 2019 Apr; 181(17):. PubMed ID: 31036138
[TBL] [Abstract][Full Text] [Related]
14. Safety of treatment for gastroparesis.
Sarosiek I; Bashashati M; McCallum RW
Expert Opin Drug Saf; 2016 Jul; 15(7):937-45. PubMed ID: 27031006
[TBL] [Abstract][Full Text] [Related]
15. Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine.
Wijemanne S; Jankovic J; Evans RW
Headache; 2016 Jan; 56(1):153-61. PubMed ID: 26573884
[TBL] [Abstract][Full Text] [Related]
16. Review article: The diagnosis and management of gastroparesis.
Haans JJ; Masclee AA
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():37-46. PubMed ID: 18081647
[TBL] [Abstract][Full Text] [Related]
17. The dual role of domperidone in gastroparesis and lactation.
Phan H; DeReese A; Day AJ; Carvalho M
Int J Pharm Compd; 2014; 18(3):203-7. PubMed ID: 25306766
[TBL] [Abstract][Full Text] [Related]
18. MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia.
Xu D; Ham AG; Tivis RD; Caylor ML; Tao A; Flynn ST; Economen PJ; Dang HK; Johnson RW; Culbertson VL
EBioMedicine; 2017 Dec; 26():132-137. PubMed ID: 29191560
[TBL] [Abstract][Full Text] [Related]
19. Prokinetics in gastroparesis.
Acosta A; Camilleri M
Gastroenterol Clin North Am; 2015 Mar; 44(1):97-111. PubMed ID: 25667026
[TBL] [Abstract][Full Text] [Related]
20. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
Stapleton J; Wo JM
Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
